4.22
Voyager Therapeutics Inc (VYGR) 最新ニュース
VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Morningstar
Levi & Korsinsky Reminds Voyager Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsVYGR - ACCESS Newswire
Lost Money on Voyager Therapeutics, Inc. (VYGR)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Wednesday - MarketBeat
Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. (VYGR) on Behalf of Investors - GlobeNewswire
Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. (VYGR) on Behalf of Investors - GlobeNewswire Inc.
Voyager Therapeutics stock hits 52-week low at $4.12 By Investing.com - Investing.com Nigeria
Voyager Therapeutics reassesses SOD1-ALS gene therapy program - ALS News Today
Wedbush Has Bearish Estimate for VYGR FY2025 Earnings - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc.VYGR - PR Newswire
Research Analysts Set Expectations for VYGR FY2029 Earnings - MarketBeat
Wedbush Predicts Lower Earnings for Voyager Therapeutics - Armenian Reporter
Voyager Therapeutics CEO Alfred Sandrock sells $74,065 in stock - MSN
Voyager Therapeutics (NASDAQ:VYGR) Receives "Outperform" Rating from Wedbush - MarketBeat
Equities Analysts Issue Forecasts for VYGR FY2025 Earnings - Defense World
Voyager Therapeutics COO Robin Swartz sells $30,927 in stock - MSN
Brokers Issue Forecasts for VYGR FY2029 Earnings - Defense World
A company insider recently sold 5,413 shares of Voyager Therapeutics Inc [VYGR]. Should You Sale? - Knox Daily
Voyager Therapeutics COO Robin Swartz sells $30,927 in stock By Investing.com - Investing.com Australia
Voyager Therapeutics' chief legal officer sells $19,393 in stock - MSN
Voyager Therapeutics CEO Alfred Sandrock sells $74,065 in stock By Investing.com - Investing.com Australia
Voyager Therapeutics’ chief legal officer sells $19,393 in stock By Investing.com - Investing.com Nigeria
Voyager Therapeutics stock hits 52-week low at $4.12 - MSN
Voyager Therapeutics' chief scientific officer sells shares worth $24,087 - MSN
Voyager Therapeutics’ chief scientific officer sells shares worth $24,087 By Investing.com - Investing.com Nigeria
Voyager Therapeutics' chief scientific officer sells shares worth $24,087 By Investing.com - Investing.com South Africa
Voyager Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView
Voyager Therapeutics' chief legal officer sells $19,393 in stock By Investing.com - Investing.com UK
Voyager Therapeutics Executives Sell Shares - TradingView
Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now - Insider Monkey
Insiders Sold Voyager Therapeutics Prematurely At US$7.47 With Stock Trading Higher - Simply Wall St
Voyager updates on SOD1 ALS gene therapy program - The Pharma Letter
Voyager Therapeutics (NASDAQ:VYGR) Given “Outperform” Rating at Wedbush - Defense World
SG Americas Securities LLC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
10 Cheap Biotech Stocks to Invest in Now - Insider Monkey
Voyager Therapeutics shifts focus for ALS therapy - MSN
Voyager Therapeutics stock tumbles after IND application delayed - MSN
Voyager Therapeutics stock tumbles after IND application delayed By Investing.com - Investing.com Canada
Voyager Therapeutics shifts focus for ALS therapy By Investing.com - Investing.com Australia
Wedbush Adjusts Price Target on Voyager Therapeutics to $9 From $11, Maintains Outperform Rating - Marketscreener.com
Voyager Provides Update on SOD1 ALS Gene Therapy Program - GlobeNewswire
Journey of Voyager's ALS gene therapy to clinic hindered by need to find alternative payload - Fierce Biotech
Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025 - Marketscreener.com
大文字化:
|
ボリューム (24 時間):